Company / Book Value per Share
Bio-Rad Laboratories Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$255.182
FY2025
5-year range
$220.557 / $453.393
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#3 of 158
Health Care
What the data says
Among 158 Health Care companies, Bio-Rad Laboratories is in the top 2% for book value per share. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $255.182.
Based on SEC 10-K filings.
$255.182 in FY2025 with a 5-year CAGR of +13.9%. Ranks 3rd among 158 companies in Health Care.
Declined from $289.367 to $255.182 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
+430.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +13.9%, indicating consistent growth.
- In FY2025, book value per share increased 15.7% year-over-year.
- Ranks #3 out of 158 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $255.182 | +15.7% |
| FY2024 | $220.557 | -23.8% |
| FY2023 | $289.367 | -9.2% |
| FY2022 | $318.806 | -29.7% |
| FY2021 | $453.393 | +240.9% |
| FY2020 | $133 | -30.6% |
| FY2019 | $191.677 | +120.3% |
| FY2018 | $86.999 | +3.0% |
| FY2017 | $84.499 | +12.7% |
| FY2016 | $75.006 | -12.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026